Platinum-Based Chemotherapy Benefits Elderly Lung Cancer Patients

The study was funded by the IFCT and the French National Cancer Institute, with support by grants from Bristol-Myers Squibb, Roche, and Pierre Fabre. Several authors, including Dr. Quoix, disclosed financial relationships with the makers of chemotherapy drugs, including carboplatin (Bristol-Myers Squibb, Roche, and Lilly). Dr. Reckamp disclosed consulting for Amgen, Genentech, and Tragara Pharmaceuticals, as well as serving on speakers bureaus for Lilly Oncology and Genentech.